{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:17:32Z","timestamp":1787912252036,"version":"build-2784847793"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006244","name":"Stichting Kinderen Kankervrij","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008039","name":"Stichting Kinder Oncologisch Centrum Rotterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background and purpose<\/jats:title><jats:p>Intrachromosomal amplification of chromosome 21 (iAMP21) is a rare subtype of B-cell precursor acute lymphoblastic leukaemia (BCP-ALL). It is unknown how iAMP21 contributes to leukaemia. The currently known commonly amplified region is 5.1 Mb.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We aimed to narrow down the common region of amplification by using high resolution techniques. Array comparative genomic hybridization (aCGH) was used to determine copy number aberrations, Affymetrix U133 Plus2 expression arrays were used to determine gene expression. Genome-wide expression correlations were evaluated using Globaltest.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We narrowed down the common region of amplification by combining copy number data from 12 iAMP21 cases with 52 cases from literature. The combined common region of amplification was 1.57 Mb, located from 36.07 to 37.64 Mb (GRCh38). This region is located telomeric from, but not including, <jats:italic>RUNX1<\/jats:italic>, which is the locus commonly used to diagnose iAMP21. This narrow region, which falls inside the Down Syndrome critical region, includes 13 genes of which the expression of eight genes was significantly upregulated compared with 143 non-iAMP21 B-other cases. Among these, transcriptional repressor <jats:italic>RIPPLY3<\/jats:italic> (also known as <jats:italic>DSCR6<\/jats:italic>) was the highest overexpressed gene (fold change = 4.2, FDR &amp;lt; 0.001) and most strongly correlated (R = 0.58) with iAMP21-related genome-wide expression changes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The more precise definition of the common region of amplification could be beneficial in the diagnosis of iAMP21 based on copy number analysis from DNA sequencing or arrays as well as stimulate functional research into the role of the included genes in iAMP21 biology.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1128560","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T12:04:40Z","timestamp":1677153880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Integrating copy number data of 64 iAMP21 BCP-ALL patients narrows the common region of amplification to 1.57 Mb"],"prefix":"10.3389","volume":"13","author":[{"given":"Femke M.","family":"Hormann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Q.","family":"Hoogkamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Boeree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Sonneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Escherich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique L.","family":"den Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402849","article-title":"Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: A study of 20 cases","volume":"17","author":"Harewood","year":"2003","journal-title":"Leukemia"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403000","article-title":"Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: An emerging molecular cytogenetic subgroup","volume":"17","author":"Soulier","year":"2003","journal-title":"Leukemia"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1515\/jtim-2016-0040","article-title":"2016 Revision to the WHO classification of acute lymphoblastic leukemia","volume":"4","author":"Wang","year":"2016","journal-title":"J Transl Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-329961","article-title":"Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood b-cell precursor acute lymphoblastic leukemia","volume":"117","author":"Rand","year":"2011","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-569228","article-title":"Blood spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease","volume":"125","author":"Harrison","year":"2015","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"11501","DOI":"10.1038\/s41598-020-68311-9","article-title":"MLPA and DNA index improve the molecular diagnosis of childhood b-cell acute lymphoblastic leukemia","volume":"10","author":"Yu","year":"2020","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.317","article-title":"An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome","volume":"28","author":"Harrison","year":"2014","journal-title":"Leukemia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.1308","article-title":"Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children\u2019s oncology group studies: A report from the children\u2019s oncology group","volume":"31","author":"Heerema","year":"2013","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-040436","article-title":"Brief report: Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.48.9377","article-title":"Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: A comparison of the MRC ALL97\/99 and UKALL2003 trials","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.80","article-title":"The role of the RAS pathway in iAMP21-ALL","volume":"30","author":"Ryan","year":"2016","journal-title":"Leukemia"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0412-1","article-title":"SH2B3 inactivation through CN-LOH 12q is uniquely associated with b-cell precursor ALL with iAMP21 or other chromosome 21 gain","volume":"33","author":"Sinclair","year":"2019","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20412","article-title":"Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle","volume":"46","author":"Robinson","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr159","article-title":"Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy","volume":"20","author":"Sinclair","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature13115","article-title":"Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia","volume":"508","author":"Li","year":"2014","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.172304","article-title":"Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21","volume":"103","author":"Sinclair","year":"2018","journal-title":"Haematologica"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1678153","article-title":"Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemia","volume":"61","author":"\u00d6fverholm","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.258","article-title":"Long-term results of Dutch childhood oncology group studies for children with acute lymphoblastic leukemia from 1984 to 2004","volume":"24","author":"Kamps","year":"2010","journal-title":"Leukemia"},{"key":"B19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/leu.2009.249","article-title":"Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97","volume":"24","author":"Escherich","year":"2010","journal-title":"Leukemia"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.031","article-title":"Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia","volume":"21","author":"Den Boer","year":"2003","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13492","article-title":"Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia","volume":"8","author":"Boer","year":"2017","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp132","article-title":"Smoothing waves in array CGH tumor profiles","volume":"25","author":"van de Wiel","year":"2009","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/1471-2164-10-401","article-title":"CGHnormaliter: An iterative strategy to enhance normalization of array CGH data with imbalanced aberrations","volume":"10","author":"van Houte","year":"2009","journal-title":"BMC Genomics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of b-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with b-cell precursor ALL","volume":"122","author":"van der Veer","year":"2013","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.193631","article-title":"Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven b-cell precursor acute lymphoblastic leukemia","volume":"104","author":"Polak","year":"2019","journal-title":"Haematologica"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96","article-title":"Variance stabilization applied to microarray data calibration and to the quantification of differential expression","volume":"18","author":"Huber","year":"2002","journal-title":"Bioinformatics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"B29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/0-387-29362-0_23","article-title":"Limma: Linear models for microarray data","volume-title":"Bioinformatics and computational biology solutions using r and bioconductor","author":"Smyth","year":"2005"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btg382","article-title":"A global test for groups of genes: testing association with a clinical outcome","volume":"20","author":"Goeman","year":"2004","journal-title":"Bioinformatics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.124941","article-title":"BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: A comparison between DCOG\/Erasmus MC and COG\/St. Jude signatures","volume":"100","author":"Boer","year":"2015","journal-title":"Haematologica"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.2685","article-title":"Isolation of two novel genes, DSCR5 and DSCR6, from down syndrome critical region on human chromosome 21q22.2","volume":"271","author":"Shibuya","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1242\/dev.071456","article-title":"RIPPLY3 is a retinoic acid-inducible repressor required for setting the borders of the pre-placodal ectoderm","volume":"139","author":"Janesick","year":"2012","journal-title":"Development"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1242\/dev.098319","article-title":"The xenopus homologue of down syndrome critical region protein 6 drives dorsoanterior gene expression and embryonic axis formation by antagonising polycomb group proteins","volume":"140","author":"Li","year":"2013","journal-title":"Dev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1242\/dev.054056","article-title":"Ripply3, a Tbx1 repressor, is required for development of the pharyngeal apparatus and its derivatives in mice","volume":"138","author":"Okubo","year":"2011","journal-title":"Development"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.010719","article-title":"The regulatory proteins DSCR6 and Ezh2 oppositely regulate Stat3 transcriptional activity in mesoderm patterning during xenopus development","volume":"295","author":"Loreti","year":"2020","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2018.05.004","article-title":"SH2B3 aberrations enriched in iAMP21 b lymphoblastic leukemia","author":"Baughn","year":"2018","journal-title":"Cancer Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with down\u2019s syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.1098992","article-title":"A chromosome 21 critical region does not cause specific down syndrome phenotypes","volume":"306","author":"Olson","year":"2004","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2949","article-title":"Triplication of a 21q22 region contributes to b cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation","volume":"46","author":"Lane","year":"2014","journal-title":"Nat Genet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.celrep.2018.10.061","article-title":"Trisomy of a down syndrome critical region globally amplifies transcription via HMGN1 overexpression","volume":"25","author":"Mowery","year":"2018","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2017.08.005","article-title":"Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal","author":"Tsuchiya","year":"2017","journal-title":"Cancer Genet"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPLUYF11HQBYRB","article-title":"Cytogenetic variation of b-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21): A multi-institutional series review","volume":"144","author":"Johnson","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17869","article-title":"Genetic characterisation of childhood b-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and multiplex ligation-dependent probe amplification","volume":"196","author":"Schwab","year":"2022","journal-title":"Br J Haematol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s13353-019-00509-8","article-title":"MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL","volume":"60","author":"Wrona","year":"2019","journal-title":"J Appl Genet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.357","article-title":"Diagnosis of intrachromosomal amplification of chromosome 21 (iAMP21) by molecular cytogenetics in pediatric acute lymphoblastic leukemia","volume":"3","author":"Duployez","year":"2015","journal-title":"Clin Case Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1128560\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T12:04:45Z","timestamp":1677153885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1128560\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":47,"alternative-id":["10.3389\/fonc.2023.1128560"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1128560","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"article-number":"1128560"}}